ロード中...
Efavirenz Stimulates HIV-1 Reverse Transcriptase RNase H Activity by a Mechanism Involving Increased Substrate Binding and Secondary Cleavage Activity
Efavirenz is a non-nucleoside reverse transcriptase inhibitor used for treating HIV/AIDS. We found that polymerization activity of a reverse transcriptase (RT) with the E478Q mutation that inactivates the RNase H catalytic site is much more sensitive to efavirenz than the wild type RT, indicating th...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2013
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3843972/ https://ncbi.nlm.nih.gov/pubmed/23806074 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/bi400618q |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|